In This Article:
As February 2025 unfolds, global markets are witnessing a dynamic period with U.S. stock indexes nearing record highs and growth stocks outpacing value shares, despite small-cap stocks trailing behind their larger counterparts. In this environment of heightened inflation and rate expectations, identifying high growth tech stocks requires a keen focus on innovation potential and resilience to macroeconomic shifts.
Top 10 High Growth Tech Companies
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Yggdrazil Group | 30.20% | 87.10% | ★★★★★★ |
| CD Projekt | 27.11% | 39.37% | ★★★★★★ |
| Ascelia Pharma | 46.09% | 66.93% | ★★★★★★ |
| Pharma Mar | 23.77% | 45.40% | ★★★★★★ |
| Xspray Pharma | 127.78% | 104.91% | ★★★★★★ |
| Alkami Technology | 21.99% | 102.65% | ★★★★★★ |
| AVITA Medical | 27.78% | 55.33% | ★★★★★★ |
| TG Therapeutics | 29.48% | 45.20% | ★★★★★★ |
| Elliptic Laboratories | 61.01% | 121.13% | ★★★★★★ |
| Lumentum Holdings | 21.25% | 118.58% | ★★★★★★ |
Click here to see the full list of 1202 stocks from our High Growth Tech and AI Stocks screener.
Let's uncover some gems from our specialized screener.
Lenovo Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lenovo Group Limited is an investment holding company that develops, manufactures, and markets technology products and services, with a market capitalization of HK$146.13 billion.
Operations: Lenovo Group's revenue primarily comes from its Intelligent Devices Group (IDG), generating $47.76 billion, followed by the Infrastructure Solutions Group (ISG) at $11.47 billion and the Solutions and Services Group (SSG) at $7.89 billion.
Lenovo Group's strategic focus on integrating artificial intelligence into its offerings is evident from its recent product launches and R&D initiatives. With an 8.2% annual revenue growth and a 15.1% rise in earnings, the company is outpacing the Hong Kong market averages of 7.9% and 11.7%, respectively, showcasing robust financial health. Notably, Lenovo's commitment to innovation is underscored by its substantial investment in R&D, which has been crucial in developing AI-driven solutions like the AI Now assistant for PCs and advanced robotics for retail environments, aligning with industry shifts towards more intelligent technologies.
Synektik Spólka Akcyjna
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Synektik Spólka Akcyjna offers products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland, with a market capitalization of PLN1.95 billion.
Operations: Synektik Spólka Akcyjna focuses on providing specialized solutions in surgery, diagnostic imaging, and nuclear medicine within Poland. The company's revenue is derived from its diverse offerings in these medical fields, supported by a market capitalization of PLN1.95 billion.